The rise and fall of NMDA antagonists for ischemic stroke.

The rise and fall of NMDA antagonists for ischemic stroke.

It has long been accepted that high concentrations of glutamate can destroy neurons, and this is the basis of the theory of excitotoxicity during brain injury such as stroke. Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists such as Selfotel, Aptiganel, Gavestinel and others failed to show...

Descripció completa

Dades bibliogràfiques
Autors principals:	Hoyte, L, Barber, P, Buchan, A, Hill, MD
Format:	Journal article
Idioma:	English
Publicat:	2004

Ítems similars

NMDA antagonists: their role in neuroprotection.
per: Small, D, et al.
Publicat: (1997)

NMDA antagonists: their role in neuroprotection.
per: Small, D, et al.
Publicat: (1997)

Do NMDA antagonists prevent neuronal injury? No.
per: Buchan, A
Publicat: (1992)

AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
per: Buchan, A, et al.
Publicat: (1993)

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
per: Buchan, A, et al.
Publicat: (1992)

Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.
per: Buchan, A, et al.
Publicat: (2000)

Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
per: Buchan, A
Publicat: (1990)

Biochemistry of ischemic stroke.
per: Barber, P, et al.
Publicat: (2003)

Time is brain: Post-marketing experience with alteplase (tPA) for acute ischemic stroke
per: Hill, MD, et al.
Publicat: (2000)

Intra-arterial therapy following intravenous alteplase for severe ischemic stroke
per: Hill, MD, et al.
Publicat: (2001)

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
per: Xue, D, et al.
Publicat: (1994)

POSTISCHEMIC TREATMENT WITH AMPA, BUT NOT NMDA, ANTAGONISTS PREVENTS CA1 NEURONAL INJURY
per: Li, H, et al.
Publicat: (1992)

Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.
per: Hill, MD, et al.
Publicat: (2000)

Understanding and managing ischemic stroke.
per: Barber, P, et al.
Publicat: (2001)

DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION
per: Xue, D, et al.
Publicat: (1992)

Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning.
per: Hoyte, L, et al.
Publicat: (2006)

Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study.
per: Hill, MD, et al.
Publicat: (2005)

HYPOTHERMIA BUT NOT NMDA RECEPTOR ANTAGONIST MK-801 ATTENUATES NEURON DAMAGE - ARE THE RESULTS CONCLUSIVE - REPLY
per: Buchan, A, et al.
Publicat: (1992)

Neuroprotection, excitotoxicicity and nmda antagonists
per: RUBENS JOSÉ GAGLIARDI
Publicat: (2000-06-01)

Animal Models of Stroke
per: Hoyte, L, et al.
Publicat: (2010)

Organised stroke care increases the numbers and the speed with which patients with acute ischemic stroke are thrombolysed
per: Kennedy, J, et al.
Publicat: (2002)

Is alteplase safe and effective in routine clinical practice for patients with ischemic stroke?
per: Buchan, A, et al.
Publicat: (2007)

Building a "brain attack" team to administer thrombolytic therapy for acute ischemic stroke.
per: Hill, MD, et al.
Publicat: (2000)

NMDA Receptor Antagonists for Treatment of Depression
per: Zeynep Ates-Alagoz, et al.
Publicat: (2013-04-01)

Effectiveness of tissue-type plasminogen activator for acute ischemic stroke: Consequences of protocol violation
per: Karbalai, H, et al.
Publicat: (1999)

NEUROPROTECTIVE PROFILE OF FPL-15896AR, A NOVEL UNCOMPETITIVE NMDA ANTAGONIST
per: Murray, R, et al.
Publicat: (1995)

Opioid Antagonist in the Treatment of Ischemic Stroke
per: Juan Fernando Ortiz, et al.
Publicat: (2021-06-01)

Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians.
per: Mateen, F, et al.
Publicat: (2010)

THE NMDA RECEPTOR-ION CHANNEL - ITS IMPORTANCE TO INVIVO ISCHEMIC-INJURY TO SELECTIVELY VULNERABLE NEURONS
per: Pulsinelli, W, et al.
Publicat: (1990)

Correction: Diagnostic Potential of the NMDA Receptor Peptide Assay for Acute Ischemic Stroke.
per: Svetlana A Dambinova, et al.
Publicat: (2013-01-01)

Informed consent for thrombolytic therapy in acute ischemic stroke.
per: Sivakumar, C, et al.
Publicat: (2005)

Acute ischaemic stroke. Thrombolysis for acute ischaemic stroke works.
per: Hill, MD, et al.
Publicat: (2000)

NMDA receptor antagonists in the treatment of neurological diseases
per: I. S. Preobrazhenskaya
Publicat: (2020-10-01)

PSYCHOPHARMACOLOGICAL PROFILE OF THE NMDA RECEPTOR ANTAGONIST MK-801
per: Iversen, S, et al.
Publicat: (1987)

Thrombolytic therapy for acute ischemic stroke - The CAEP Position Statement: another perspective.
per: Hill, MD, et al.
Publicat: (2001)

Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemia.
per: Pulsinelli, W, et al.
Publicat: (1993)

Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.
per: Barber, P, et al.
Publicat: (2005)

Cold Pain Threshold and Role of NMDA Receptor Antagonists
per: Poroshat Nazemi, et al.
Publicat: (2019-01-01)

Thrombolysis for acute ischemic stroke in patients older than 80 years
per: N, S, et al.
Publicat: (2006)

The Canadian activase for stroke effectiveness study (CASES)
per: Hill, MD, et al.
Publicat: (2000)